Condition
Haemophilia A
Locations
United States
Start date
18/11/2025
Identifiers
Trial ID NN7442-8255,
NCT number NCT07238816,
Eudract number Not Available
NCT number NCT07238816,
Eudract number Not Available
Summary
The purpose of this study is to test a new medicine called Inno8. The study will test how eating and drinking before and after taking Inno8 affects how well it is absorbed in the stomach. The study consists of four arms. Participants will take the study medicine after an overnight fast. How long participants will need to fast depends on which group participants are in. After taking the study medicine, participants will need to fast again. The study will last for up to 9.5 weeks.
Trial Overview:
Treatment
DRUG: NNC0442-0344 A
Study type
INTERVENTIONAL
Trial duration
Nov 18 2025 - Apr 29 2026
Participants
80
Phase
I
Are you eligible?
Gender
MALE
Age
18 to 45 years old
Find out how you can participate
Questions or concerns
Do you have any question about what it’s like being a clinical volunteer? Have a look at our answers to frequently asked questions.
This site contains information about clinical trials sponsored by Novo Nordisk. It is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. The information on this site should not be relied on as the basis for any decision or action. Only a physician can determine whether a specific product is correct for a particular patient. If you have questions regarding any information contained on this site you should consult a physician.